Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug Company

AI Briefing

• – Bristol Myers Squibb and Pfizer announce partnership with Mark Cuban Cost Plus Drug Company to make Eliquis (apixaban) available at discounted prices.
• – Eliquis is used to prevent stroke and blood clots in patients with atrial fibrillation or deep vein thrombosis/ pulmonary embolism.
• – The partnership aims to increase access to Eliquis for patients who may not be able to afford the medication at full price.